From early-stage development to brand rejuvenation, Healogix delivers pragmatic, commercially viable business strategies for bio-pharmaceutical companies. We apply unparalleled industry, therapeutic category and methodological knowledge to critical commercialization issues.
Pharmaceutical research, customer expectations, payer requirements, physician attitudes, sales rep needs are all moving targets. Healogix blends experienced consultation with leading-edge market research, proprietary technology and unparalleled insight.
Harris Kaplan, CEO, was instrumental in developing and launching more than 75 new Rx products, including blockbusters Lipitor, Viagra, Crestor, Rituxan, Nexium, Norvasc and Herceptin. He heads a seasoned team of consultants and researchers who have expertise in both the pharma and biotech industries.